Andrew Albright
Impact in
Papers in
- Co-authors
- Francisco González‐Scarano (16 shared papers)Jared Lunceford (15 shared papers)Andrey Loboda (13 shared papers)Mark Ayers (13 shared papers)Michael Nebozhyn (8 shared papers)Antoni Ribas (5 shared papers)Erin Murphy (5 shared papers)Jennifer H. Yearley (4 shared papers)
- Journals
- Journal of Clinical Oncology (7 papers)Journal of Virology (5 papers)Journal of NeuroVirology (5 papers)Journal for ImmunoTherapy of Cancer (3 papers)Virology (2 papers)
- Partner nations
- United StatesJapanSpain
In The Last Decade
Andrew Albright
41 papers receiving 4.6k citations
Andrew Albright's Hit Papers
Peers
Comparison fields: 5 of 99
- Virology 840
- Oncology 2.2k
- Immunology 1.4k
- Neurology 382
- Cancer Research 445
Countries citing papers authored by Andrew Albright
This map shows the geographic impact of Andrew Albright's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew Albright with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew Albright more than expected).
Fields of papers citing papers by Andrew Albright
This network shows the impact of papers produced by Andrew Albright. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew Albright. The network helps show where Andrew Albright may publish in the future.
Co-authors
The 25 scholars most cited alongside Andrew Albright, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 41 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | IFN-γ–related mRNA profile predicts clinical response to PD-1 blockade Hit paper breakdown → | 2017 | 2449 |
| 2 | 1999 | 251 | |
| 3 | 2015 | 170 | |
| 4 | 1998 | 159 | |
| 5 | 2003 | 133 | |
| 6 | 1996 | 116 | |
| 7 | 1998 | 113 | |
| 8 | 2022 | 100 | |
| 9 | 2006 | 85 | |
| 10 | 2019 | 77 | |
| 11 | 2001 | 76 | |
| 12 | 1998 | 74 | |
| 13 | 2019 | 74 | |
| 14 | 2019 | 74 | |
| 15 | 2016 | 69 | |
| 16 | 2019 | 67 | |
| 17 | 1996 | 61 | |
| 18 | 2022 | 59 | |
| 19 | 2004 | 51 | |
| 20 | 2021 | 45 |
About Andrew Albright
Andrew Albright is a scholar working on Oncology, Virology, Neurology, Immunology and Cancer Research, having authored 41 papers that have together received 4.6k indexed citations. Recurring topics across this work include HIV Research and Treatment (15 papers), Cancer Immunotherapy and Biomarkers (13 papers), Neuroinflammation and Neurodegeneration Mechanisms (9 papers), Cancer Genomics and Diagnostics (7 papers), Immune cells in cancer (4 papers), Colorectal Cancer Treatments and Studies (4 papers), Herpesvirus Infections and Treatments (3 papers) and Esophageal Cancer Research and Treatment (3 papers). The work is most often cited by research in Virology (840 citations), Oncology (2.2k citations), Immunology (1.4k citations), Neurology (382 citations) and Cancer Research (445 citations). Andrew Albright has collaborated with scholars based in United States, Japan and Spain. Frequent co-authors include Francisco González‐Scarano, Jared Lunceford, Andrey Loboda, Mark Ayers, Michael Nebozhyn, Antoni Ribas, Erin Murphy, Jennifer H. Yearley, Jonathan D. Cheng and Tanguy Y. Seiwert. Their work appears in journals such as Journal of Clinical Oncology, Journal of Virology, Journal of NeuroVirology, Journal for ImmunoTherapy of Cancer and Virology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.